About This Webinar
Step into the next generation of clinical trials, where predictive intelligence enables faster, smarter, and more confident decision-making across the trial lifecycle. Discover how AI-powered insights are reshaping clinical research by improving study feasibility, accelerating site activation, and optimising trial execution.
Key Topics
- The future of clinical development is here. Are you ready?
- Clinical trials are evolving as traditional, protocol-driven approaches struggle to keep pace with the demand for faster timelines, smarter decisions, and higher success rates. Predictive intelligence, AI-driven insights, and advanced analytics are beginning to reshape how trials are designed, operationalized, and optimized bringing greater foresight to protocol development and site feasibility.
- Join us for an exclusive webinar exploring how leading organizations are moving beyond static protocols toward intelligent, adaptive, and predictive clinical trial ecosystems enabling faster study activation, smarter site decisions, and more confident trial execution.
What You'll Learn
- How predictive intelligence is transforming trial design and feasibility planning.
- Leveraging AI-driven insights and advanced analytics to reduce operational delays and trial costs.
- Enhancing patient recruitment through informed decision making.
- Applying risk-based monitoring and adaptive trial designs to manage trial risk and improve execution.
- Building an integrated data foundation across clinical trial operations.
Register for the webinar
Speakers
Greg Licholai
Chief Strategy Officer, Syneos Health
Dr. Greg Licholai is Chief Strategy Officer at Syneos Health. Previously, Dr. Licholai held senior leadership roles at ICON plc, Moderna Therapeutics, Castle Creek Pharmaceuticals, and McKinsey & Co., where leadership included healthcare data and innovation. Dr. Licholai is on faculty at Yale School of Management and has been a visiting faculty member at Harvard Business School. Additional experience includes executive roles at Proteostasis, Amicus Therapeutics, and Medtronic Neurological, as well as venture investing with Domain Associates and co-founding Immunome Therapeutics.
Ravinder Singh
Global Delivery Head - HLS, Tech Mahindra
Ravinder leads end-to-end delivery for Tech Mahindra’s Healthcare and Life Sciences (HLS) vertical, driving innovation through industry-focused solutions and AI-led transformation for global clients. With over 27 years of experience, Ravinder is a recognised thought leader in digital healthcare, AI transformation, and the healthcare value chain, with deep expertise across Providers, Payers, Pharma, and Medical Devices, as well as Clinical R&D and global healthcare regulations.
Ajay Nyamati
Co-Founder and CEO, Kitsa, Inc.
Ajay Nyamati is the Co-Founder and CEO of Kitsa, focused on transforming how clinical trials move from protocol design to execution. His work centers on building intelligent platforms that improve protocol feasibility, connect sponsors with the right research sites, and accelerate patient recruitment. Ajay leads product strategy, partnerships, and growth across the global clinical research ecosystem.
Kristin Ambrosini
GTM Specialist, AWS
Kristin Ambrosini, PhD is a Go‑To‑Market (GTM) Specialist at Amazon Web Services (AWS), where she helps organizations translate advanced cloud and AI technologies into scalable, real‑world business impact. She works cross‑functionally with technical, sales, and business leaders to design and execute GTM strategies that accelerate adoption and drive customer outcomes.
